Nerve growth factor in the urine of patients with idiopathic detrusor overactivity and overactive bladder without detrusor overactivity


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The purpose was to determine the concentration of the neurotrophin nerve growth factor in urine to assess its possible role as a marker in the diagnosis of various forms of overactive bladder. The study included patients with urinary frequency and urgency: 21 patients with idiopathic detrusor overactivity, 18 - with overactive bladder without detrusor overactivity and 11 healthy volunteers (control group). The level of nerve growth factor in the urine was determined in all participants of the study by the enzyme immunoassay (ELISA). In the control group the average ratio of nerve growth factor level to the level of urine creatinine was 0,2 ± 0,06, in patients with overactive bladder without detrusor overactivity - 0,33 ± 0,06 (p> 0.05). In patients with idiopathic detrusor overactivity the rate was significantly higher and amounted to 6,04 ± 0,9 (p <0.05). Therefore, measurement of the concentration of nerve growth factor in the urine may be used for differential diagnosis of the presence or absence of detrusor overactivity in patients with overactive bladder.

Full Text

Restricted Access

About the authors

G. G Krivoborodov

Russian National Research Medical University n.a. N.I. Pirogov

Email: dr.krivoborodov@hotbox.ru
Department of Urology

E. F Kolesanova

Russian National Research Medical University n.a. N.I. Pirogov

Department of Urology

E. I Tur

Russian National Research Medical University n.a. N.I. Pirogov

Department of Urology

N. S Efremov

Russian National Research Medical University n.a. N.I. Pirogov

Department of Urology

References

  1. Guralnick M.L., Grimsby G., Liss M., Szabo A., O'Connor R.C. Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity. Int. Urogynecol. J. 2010;21:325-329.
  2. Haylen B.T., Chetty N., Logan V., Schulz S., Verity L., Law M., Zhou J. Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity? Int. Urogynecol. J. Pelvic. Floor. Dysfunct. 2007;18:123-128.
  3. Southgate J., Varley C.L., Garthwaite M.A., Hinley J., Marsh F., Stahlschmidt J., Trejdosiewicz L.K., Eardley I. Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int. 2007;99(6):1506-1516.
  4. Steers W.D., Kolbeck S., Creedon D., Tuttle J.B. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J. Clin. Invest. 1991;88:1709-1715.
  5. Okragly A.J., Niles A.L., Saban R., Schmidt D., Hoffman R.L., Warner T.F., Moon T.D., Uehling D.T., Haak-Frendscho M. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J. Urol. 1999;161:438-441.
  6. Lowe E.M., Anand P., Terenghi G., Williams-Chestnut R.E., Sinicropi D.V., Osborne J.L. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br. J. Urol. 1997;79:572-577.
  7. Tuttle J.B., Steers W.D., Albo M., Nataluk E. Neural input regulates tissue NGF and growth of the adult urinary bladder. J. Auton. Nerv. Syst. 1994;49:147-158.
  8. Dupont M.C., Spitsbergen J.M., Kim K.B., Tuttle J.B., Steers W.D. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J. Urol. 2001;166:1111-1118.
  9. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., van Kerrebroeck P., Victor A., Wein A.; Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodyn. 2002;21(2):167-178.
  10. Родионов И.М. Фактор роста нервов, гипертрофия и деструкция симпатической системы в эксперименте. Соросовский образовательный журнал. 1996;3:17-22.
  11. Vizzard M.A. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp. Neurol. 2000;161:273-284.
  12. Yoshimura N. Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog. Neurobiol. 1999;57:583-606.
  13. Seki S., Sasaki K., Igawa Y., et al. Detrusor overactivity induced by increased levels of nerve growth factor in bladder afferent pathways in rats. Neurourol. Urodyn. 2003;22:375-377.
  14. Vizzard M.A. Neurochemical plasticity and the role of neurotrophic factors in bladder reflex pathways after spinal cord injury. Prog. Brain Res. 2006;152:97-115.
  15. Lamb K., Gebhart G.F., Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J. Pain. 2004;5:150-156.
  16. Yoshimura N., Bennett N.E., Hayashi Y., Ogawa T., Nishizawa O., Chancellor M.B., de Groat W.C., Seki S. Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. J. Neurosci. 2006;26:10847-10855.
  17. Zvara P., Vizzard M.A. Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered mic- turition circuitry in the lumbosacral spinal cord. BMC Physiol. 2007;7:9.
  18. Liu H.T., Kuo H.C. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J. Urol. 2008;179: 2270-2274.
  19. Kuo H.C., Liu H.T., Chancellor M.B. Can urinary nerve growth factor be a biomarker for overactive bladder? Rev. Urol. 2010;12(2-3):e69-77.
  20. Shalom D.F., Pillalamarri N., Xue X., Kohn N., Lind L.R., Winkler H.A., Metz C.N. Sacral Nerve Stimulation reduces elevated urinary nerve growth factor levels in women with symptomatic detrusoroveractivity. Am. J. Obstet. Gynecol. 2014;211(5):561.
  21. Knippschild S., Frohme C., Olbert P., Hofmann R., Hegele A. Value of nerve growth factor levels in overactive bladder syndrome: alterations after botulinum toxin therapy Urologe A. 2012;51(3):379-383.
  22. Kim J.C., Park E.Y., Seo S.I., Park Y.H., Hwang T.K. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J. Urol. 2006;175:1773-1776.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Bionika Media